MannKind and Rose Pharma Partner on Inhaled GLP-1
Danbury, Connecticut, USA, September 9, 2026 MannKind Corporation and Rose Pharma Inc. have entered into a licensing and collaboration...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Danbury, Connecticut, USA, September 9, 2026 MannKind Corporation and Rose Pharma Inc. have entered into a licensing and collaboration...
Dublin, Ireland, September 9, 2026 LUMA Vision has secured additional U.S. FDA clearance for its VERAFEYEâ„¢ procedural intelligence platform,...
Cambridge, Massachusetts, USA, September 8, 2026 LabCentral has launched The Loop, a new program designed to help international biotech...
